Home Tags Diabetes: Type II

Tag: Diabetes: Type II

Higher consumption of nuts

Eating Nuts Tied to Reduced CVD Incidence, Death in T2DM Patients

Reduced risk seen for total CVD, coronary heart disease incidence for men and women
A deep learning-enhanced device can accurately detect diabetic retinopathy

Deep Learning-Enhanced Device Detects Diabetic Retinopathy

Device sensitivity/specificity 100/97.8 percent for vision-threatening diabetic retinopathy
Roux-en-Y gastric bypass is associated with high levels of type 2 diabetes remission at one year

T2DM Initially Remits in Majority Who Undergo Gastric Bypass

Roux-en-Y gastric bypass linked to significantly lower risk for microvascular complications
Irrespective of age and weight

Type 2 Diabetes Risk Up With PCOS Regardless of BMI

PCOS one of most influential predictors of T2DM after adjustment for BMI, education, family history
Switching from analogue to human insulin is associated with a small increase in hemoglobin A1c levels

Small Increase in HbA1c Seen With Switch to Human Insulin in T2DM

No increase in serious hypoglycemia, hyperglycemia after switch from analogue to human insulin
Physicians need to take an active role in prescribing specific exercise training in patients with both type 2 diabetes mellitus and cardiovascular disease

Doctors Should Encourage Exercise in Patients With Diabetes, CV Disease

Recommendations suggest doctors prescribe individualized exercise training for these patients
Poor glycemic control is associated with an increased risk for fracture in patients with type 1 diabetes mellitus but not in patients with type 2 diabetes mellitus

Poor Glycemic Control in Type 1 Diabetes Tied to Fracture Risk

Fracture risk up with T2DM and current use of rosiglitazone, pioglitazone regardless of glycemic control
Use of the oral hepatoselective glucokinase activator TTP399 for type 2 diabetes does not cause hypoglycemia and has no detrimental effect on plasma lipids or liver enzymes

Oral Hepatoselective Glucokinase Activator Promising in T2DM

Clinically significant and sustained reduction in glycated hemoglobin was observed with TTP399
Ertugliflozin appears safe and effective at improving long-term glycemic control among adults with type 2 diabetes mellitus inadequately controlled on metformin

Ertugliflozin Seems Safe, Effective for Type 2 Diabetes Treatment

Improvements seen in HbA1c, fasting glucose, body weight, blood pressure over two years
For individuals with normal fasting glucose but not those with impaired fasting glucose

Components of Ideal Cardio Health Cut Diabetes Risk

Lower risk for diabetes seen for those with normal fasting glucose, not impaired fasting glucose